Condition: Dry Eye Disease (DED) · Sponsor: Oculis
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
This description comes directly from the study's public registry record.
Oculis Chief Development Officer · 617 928 5886 · info@oculis.com
Always discuss trial participation with your own doctor first.
| East West Eye Institute | Aliso Viejo, California, United States | Recruiting |
| Orange County Ophthalmology | Garden Grove, California, United States | Recruiting |
| Global Research Management | Glendale, California, United States | Recruiting |
| LoBue Laser and Eye Medical Center | Murrieta, California, United States | Recruiting |
| Eye Research Foundation | Newport Beach, California, United States | Recruiting |
| North Bay Eye Associates, Inc. | Petaluma, California, United States | Recruiting |
| Vision Institute | Colorado Springs, Colorado, United States | Recruiting |
| Segal Drug Trials, Inc. | Delray Beach, Florida, United States | Recruiting |
| Oculus Research, Inc. | Garner, North Carolina, United States | Recruiting |
| CORE, Inc | Shelby, North Carolina, United States | Recruiting |
| Scott & Christie and Associates | Cranberry Township, Pennsylvania, United States | Recruiting |
| Erie Retina Research | Erie, Pennsylvania, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07548632